Vaccines

04 Jun 2009 Apthera Announces Product License Agreement With Kwang Dong Pharmaceutical Co., Ltd.
04 Jun 2009 ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
04 Jun 2009 ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
03 Jun 2009 Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX(r) From the European Medicines Agency
31 May 2009 Positive, Clinically Significant Phase III Results for Personalized Anti-Cancer Vaccine, BiovaxID®, Presented at ASCO Plenary Session
29 May 2009 Intercell AG Announces First Subject Enrolled in a Phase II Trial for the further development of its investigational Vaccine Enhancement Patch to improve Pandemic Influenza prevention in Collaboration with U.S. Department of Health and Human Services (HHS
27 May 2009 AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
26 May 2009 Takeda to License Vaccine for Haemophilus Influrnzae Type B from Novartis
26 May 2009 Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate
26 May 2009 Senesco Announces H1N1 Influenza Survival Test Results in Mice
26 May 2009 ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
25 May 2009 Bioniche Phase III Clinical Trial with Urocidin™ Progressing Well
22 May 2009 PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
21 May 2009 Vical Advances H1N1 Pandemic Influenza (Swine Flu) Vaccine
14 May 2009 ALPHAVAX ANNOUNCES FULL ENROLLMENT IN PHASE I/II STUDY OF ACTIVE IMMUNOTHERAPY IN PATIENTS WITH ADVANCED OR METASTATIC CANCER
13 May 2009 Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
13 May 2009 AlphaVax Announces Promising Results in Melanoma Studies
12 May 2009 Sanofi-aventis builds a New Vaccine Manufacturing Facility in France with an investment of 350 million euros
12 May 2009 Medicago succesfully expresses VLP antigen for A H1N1 strain
08 May 2009 Juvaris BioTherapeutics’ Universal Influenza Vaccine Protects from Lethal H1N1 and H3N2 Challenges in Pre-Clinical Studies
07 May 2009 FDA Grants Priority Review Status to Prevnar 13 Marketing Application
05 May 2009 Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate
30 Apr 2009 Novartis investigational adjuvanted (MF59) pre-pandemic avian influenza vaccine Aflunov® shows long lasting, broadly cross-protective immune response
29 Apr 2009 OXFORD BIOMEDICA REGAINS RIGHTS TO ITS TROVAX® CANCER VACCINE
29 Apr 2009 Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top